Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberWO2016071426 A1
Publication typeApplication
Application numberPCT/EP2015/075765
Publication date12 May 2016
Filing date5 Nov 2015
Priority date7 Nov 2014
Also published asCA2966796A1, CN107074776A, EP3018131A1, EP3215507A1
Publication numberPCT/2015/75765, PCT/EP/15/075765, PCT/EP/15/75765, PCT/EP/2015/075765, PCT/EP/2015/75765, PCT/EP15/075765, PCT/EP15/75765, PCT/EP15075765, PCT/EP1575765, PCT/EP2015/075765, PCT/EP2015/75765, PCT/EP2015075765, PCT/EP201575765, WO 2016/071426 A1, WO 2016071426 A1, WO 2016071426A1, WO-A1-2016071426, WO2016/071426A1, WO2016071426 A1, WO2016071426A1
InventorsJan-Georg Peters, Jürgen STIEHL, Kai Lovis
ApplicantBayer Pharma Aktiengesellschaft
Export CitationBiBTeX, EndNote, RefMan
External Links: Patentscope, Espacenet
Synthesis of copanlisib and its dihydrochloride salt
WO 2016071426 A1
Description  available in English
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
WO2008070150A1 *5 Dec 200712 Jun 2008Bayer Schering Pharma AktiengesellschaftSubstituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Non-Patent Citations
Reference
1 *FUJIOKA ET AL: "One-pot synthesis of imidazolines from aldehydes: detailed study about solvents and substrates", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 63, no. 3, 13 December 2006 (2006-12-13), pages 638 - 643, XP005802290, ISSN: 0040-4020, DOI: 10.1016/J.TET.2006.11.007
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
WO2017049983A1 *1 Jul 201630 Mar 2017苏州立新制药有限公司库潘尼西的制备方法
Classifications
International ClassificationC07D233/24, C07D295/088, C07D487/04
Cooperative ClassificationC07D487/04, C07D233/24, C07D295/088
Legal Events
DateCodeEventDescription
22 Jun 2016121Ep: the epo has been informed by wipo that ep was designated in this application
Ref document number: 15790141
Country of ref document: EP
Kind code of ref document: A1
10 Apr 2017REEP
Ref document number: 2015790141
Country of ref document: EP
28 Apr 2017ENPEntry into the national phase in:
Ref document number: 20177011704
Country of ref document: KR
Kind code of ref document: A
1 May 2017ENPEntry into the national phase in:
Ref document number: 2017523873
Country of ref document: JP
Kind code of ref document: A
4 May 2017ENPEntry into the national phase in:
Ref document number: 2966796
Country of ref document: CA
8 May 2017NENPNon-entry into the national phase in:
Ref country code: DE
11 May 2017ENPEntry into the national phase in:
Ref document number: 2015341779
Country of ref document: AU
Date of ref document: 20151105
Kind code of ref document: A
30 May 2017REGReference to national code
Ref country code: BR
Ref legal event code: B01A
Ref document number: 112017009471
Country of ref document: BR